Contrast Agents

Contrast Agents

Non-enhanced CT scans for suspected renal colic often detect incidental findings.

Case History: 36-year-old Asian male presented with complaints of a first episode of generalized tonic-clonic convulsions

The FDA has approved Bayer’s Gadavist injection for use with MRI in pediatric patients younger than 2.

Lumason by Bracco Diagnostics is the latest ultrasound contrast agent to receive FDA approval.

Cone-beam CT is preferential to multislice spiral CT for hard-contrast objects, study says.

Intravenous contrast material for CT appears to be safe for most patients, including those with a predisposition to nephrotoxicity.

The FDA has given Bayer’s Gadavist approval for use with MRI of the breast to evaluate malignant breast disease.


Subscribe to Contrast Agents on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.